Cardiac side effects of anticancer treatments: new mechanistic insights
about
Neuregulin as a heart failure therapy and mediator of reverse remodelingRisk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study.A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyCancer chemotherapy and cardiac arrhythmias: a review.Aspartate facilitates mitochondrial function, growth arrest and survival during doxorubicin exposure.Mechanism-based engineering against anthracycline cardiotoxicity.Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
P2860
Q26991903-ACC35B4F-849C-4051-9066-E4A21216C336Q34049037-9BAA172C-E988-4ACB-8823-3DB19EBF67AAQ37052852-804DAAC3-A30A-4849-B510-31FF5916D9E2Q38313870-B7083C50-3F18-4BC4-BE39-866D5EFA5AE6Q39983530-B2DF1259-847D-45FD-96F6-D661103F4387Q42835370-2A2D0961-D5BC-40EC-89C4-95EF4EE14E7DQ50420344-A1FDF03A-AFBF-4263-BBD2-AFA6191CB5FE
P2860
Cardiac side effects of anticancer treatments: new mechanistic insights
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cardiac side effects of anticancer treatments: new mechanistic insights
@en
type
label
Cardiac side effects of anticancer treatments: new mechanistic insights
@en
prefLabel
Cardiac side effects of anticancer treatments: new mechanistic insights
@en
P2093
P2860
P1476
Cardiac side effects of anticancer treatments: new mechanistic insights
@en
P2093
Carrie Geisberg
Douglas B Sawyer
Laura Pentassuglia
P2860
P2888
P304
P356
10.1007/S11897-012-0098-4
P577
2012-09-01T00:00:00Z